Literature DB >> 20816529

Call for withdrawal of LABA single-therapy inhaler in asthma.

Richard Beasley1, Kyle Perrin, Mark Weatherall, Meme Wijesinghe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816529     DOI: 10.1016/S0140-6736(10)61158-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

Review 2.  Granulocyte-targeted therapies for airway diseases.

Authors:  Luciana P Tavares; Hong Yong Peh; Wan Shun Daniel Tan; Hadas Pahima; Pasquale Maffia; Ekaterini Tiligada; Francesca Levi-Schaffer
Journal:  Pharmacol Res       Date:  2020-05-04       Impact factor: 7.658

Review 3.  Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies.

Authors:  Gimena Hernández; Mónica Avila; Angels Pont; Olatz Garin; Jordi Alonso; Laurent Laforest; Christopher J Cates; Montserrat Ferrer
Journal:  Respir Res       Date:  2014-07-19

4.  Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.

Authors:  George Bardsley; Peter Daley-Yates; Amanda Baines; Rodger Kempsford; Mathew Williams; Tony Mallon; Irene Braithwaite; Kylie Riddell; Shashidhar Joshi; Philippe Bareille; Richard Beasley; James Fingleton
Journal:  Respir Res       Date:  2018-07-13

5.  Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.

Authors:  Bright I Nwaru; Magnus Ekström; Pål Hasvold; Fredrik Wiklund; Gunilla Telg; Christer Janson
Journal:  Eur Respir J       Date:  2020-04-16       Impact factor: 16.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.